After a promising start, biotech IPOs all but fizzled out this year, but LB Pharmaceuticals is hoping that won't stymy its chances of completing a Nasdaq listing. New York-based LB is hoping to raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback